SUBSCRIBE
SUBSCRIBE
News   Deals

Basilea Pharmaceutica Rises Most in 11 Months on Speculation About Takeover Approaches

January 6, 2011 | 
1 min read
Bloomberg -- Basilea Pharmaceutica AG rose the most in 11 months in Zurich trading after Helvea SA said the company’s low valuation, cash reserves and portfolio of anti- infectives make it an “imminent” takeover target.
Mergers & acquisitions
MORE ON THIS TOPIC
Shanghai.China-Feb.25th 2022: Pfizer company sign on office building. Pharmaceutical and biotechnology corporation
Obesity
After Metsera Battle, Pfizer Heads to China for Another Obesity Deal Worth up to $1.9B
December 9, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Microscope icon. Molecule and communication background. Connected lines with dots.
China
With Chinese Assets in Hand, Pharma Is Wondering What Else Can Be Learned
December 9, 2025
 · 
3 min read
 · 
Annalee Armstrong
Aircrafts landing and taking off at airport by night - vector illustration
Venture capital
Lilly, Novo GLP-1 Pricing Plans Clear Runway For Future Competitors
December 3, 2025
 · 
2 min read
 · 
Annalee Armstrong
Creative sketch collage of business people handshake gesture approval project development success colleagues cooperation support.
Gene editing
Regeneron Makes $275M Gene Editing Play With Tessera Partnership Targeting AATD
December 1, 2025
 · 
1 min read
 · 
Tristan Manalac